About 12,400 results
- The Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS) is a clinical trial designed to compare the efficacy of isradipine (2.5 or 5 mg b.i.d.) with hydrochlorothiazide (12.5 or 25 mg b.i.d.) in retarding the progression of early carotid atherosclerosis as monitored by high-resolution B-mode ultrasonography.pubmed.ncbi.nlm.nih.gov/1720479/
Explore further
MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study.
Multicenter isradipine diuretic atherosclerosis study (MIDAS).
Final outcome results of the Multicenter Isradipine Diuretic ...